Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: A long-term analysis

Cancer

Volumn 101, Issue 5, 2004, Pages 1028-1035

  Ständer, Marko ^a   Peraud, Aurelia ^a   Leroch, Barbara ^a   Kreth, Friedrich W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Astrocytoma; Genetic alteration; Low grade glioma; Oligoastrocytoma; P53; Prognosis; Survival

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MEDICAL INFORMATION; NEUROSURGERY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PUBLICATION; RETROSPECTIVE STUDY; TP53 GENE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; ASTROCYTOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; WORLD HEALTH ORGANIZATION;

EID: 4143109151     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20432     Document Type: Article

References (17)

1. Bauman G, Lote K, Larson D, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys. 1999;45:923-929.
2. Ishii N, Tada M, Hamou MF, et al. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene. 1999;18: 5870-5878.
3. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15:1294-1301.
4. Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol. 1997;15:3129-3140.
5. Louis DN, von Deimling A, Chung RY, et al. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol. 1993;52:31-38.
6. Maintz D, Fiedler K, Koopmann J, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol. 1997;56:1098-1104.
7. Nakamura M, Konishi N, Tsunoda S, et al. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology. 2000;58:108-116.
8. Nieder C, Petersen S, Petersen C, Thames HD. The challenge of p53 as prognostic and predictive factor in gliomas. Cancer Treat Rev. 2000;26:67-73.
9. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low grade glioma. J Clin Oncol. 2002;20:2076-2084.
10. Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol. 1996;55:822-831.
11. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature. 1992;355:846-847.
12. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst. 1994;86:1011-1017.
13. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res. 1997;3:523-530.
14. Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO Grade II astrocytomas and oligoastrocytomas. Clin Cancer Res. 2002;8: 1117-1124.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
16. Cox DR. Regression models and life tables. J R Stat Soc. 1972; 34:187-220.
17. Kreth FW, Faist M, Rossner R, Volk B, Ostertag CB. Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. Cancer. 1997;79:370-379.